Surgical-only treatment of pancreatic and extra-pancreatic metastases from renal cell carcinoma. Quality of life and survival analysis
Background: Treatment of pancreatic metastases (PM) from renal cell carcinoma (RCC) is still an issue between
surgeons and oncologists, in the era of target-therapy.
Methods: Data from 26 patients undergoing resection of PM and extra-PM from RCC, with R0 intention were
retrospectively analysed. No one received adjuvant chemotherapy. Patients were divided into two groups; Group A
comprehends 14 patients who developed synchronous (5) or methacronous (9) extra-PM. Group B comprehends 12
patients that developed PM only.